Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial

Autor: Kim, Se Ik, Joung, Je-Gun, Kim, Yoo-Na, Park, Junsik, Park, Eunhyang, Kim, Jae-Weon, Lee, Sungyoung, Lee, Jung Bok, Kim, Sunghoon, Choi, Chel Hun, Kim, Hee Seung, Lim, Jinyeong, Chung, Jongsuk, Kim, Byoung-Gie, Lee, Jung-Yun
Zdroj: In Gynecologic Oncology March 2024 182:7-14
Databáze: ScienceDirect